- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer - Abstract
September 16, 2013
Clinical decision support system for early detection of prostate cancer from benign hyperplasia of prostate - Abstract
September 16, 2013
Classifier-free, integrated genomic predictions of prostate cancer recurrence - Abstract
September 16, 2013
Pathobiology and management of prostate cancer-induced bone pain: Recent insights and future treatments - Abstract
September 14, 2013
Role of prostate volume in the early detection of prostate cancer in a cohort with slowly increasing prostate specific antigen - Abstract
September 14, 2013
Outcomes of Gleason score ≤ 8 among high risk prostate cancer treated with (125)I low dose rate brachytherapy based multimodal therapy - Abstract
September 14, 2013
Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes - Abstract
September 14, 2013
Severity of hematuria effects resolution in patients treated with hyperbaric oxygen therapy for radiation-induced hematuria - Abstract
September 13, 2013
Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer - Abstract
September 13, 2013
Taxane mechanisms of action: Potential implications for treatment sequencing in metastatic castration-resistant prostate cancer - Abstract
September 12, 2013
Quality of prostate cancer care among rural men in the Veterans Health Administration - Abstract
September 12, 2013
Oncologic outcomes following radical prostatectomy in the active surveillance era - Abstract
September 12, 2013
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berli - Abstract
September 12, 2013
Re-implantation after insufficient primary 125-I permanent prostate brachytherapy - Abstract
September 12, 2013